Clinical trial
Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in…
NCT00429364 · Carelon Research, Other · Completed
Key facts
| NCT number | NCT00429364 |
|---|---|
| Title | Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome |
| Official title | Trial of Beta Blocker Therapy (Atenolol) Versus Angiotensin II Receptor Blocker Therapy (Losartan) in Individuals With Marfan Syndrome (A Trial Conducted by the Pediatric Heart Network) |
| Lead sponsor | Carelon Research, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH FDA Office of Orphan Products Development U.S. Fed National Marfan Foundation |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Marfan Syndrome |
| Intervention type | Drug |
| Interventions | Losartan Potassium, Atenolol |
| Enrollment | 608 |
| Start date | Jan 1, 2007 |
| Primary completion | Feb 1, 2014 |
| Completion | Feb 1, 2014 |
| First posted | Jan 31, 2007 |
| Last update posted | Mar 7, 2025 |
| Countries | Belgium, Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: